BFM
QTTB icon

Boothbay Fund Management’s Q32 Bio QTTB Stock Holding History

Boothbay Fund Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
+130,427
New +$1.09M 0.02% 812
2024
Q3 		– Sell
-29,575
Closed -$531K – 1988
2024
Q2 		$531K Buy
+29,575
New +$708K 0.01% 973

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Boothbay Fund Management's QTTB Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Q32 Bio (QTTB) in Q2 2026: 130,427 shares worth $1.66M. The stake represents 0.02% of the portfolio and ranks #812 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in QTTB as recently as Q2 2024.

Boothbay Fund Management first reported a position in QTTB in Q2 2024 and has held it in 2 quarters since. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Boothbay Fund Management held 130,427 shares of Q32 Bio worth $1.66M as of Q2 2026.
  • Q32 Bio was a new Boothbay Fund Management position in Q2 2026.
  • Q32 Bio made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #812 holding.
  • Boothbay Fund Management first reported a position in Q32 Bio in Q2 2024 and has held it in 2 quarters since.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.